Coronavirus Outbreak

New Omicron Variants Not Causing Significant Rise In Hospitalisations In Maharashtra: Experts

The new variants of Omicron, XXB and BQ.1, have not led to any significant rise in coronavirus infections and hospitalisations in Maharashtra, experts have said

Published

on

The Indian SARS-CoV-2 Genomics Consortium (INSACOG), in a statement, said it was keeping a close watch on the emergence and evolution of XBB and XBB.1 and any new sub-lineages

Mumbai: The new variants of Omicron, XXB and BQ.1, have not led to any significant rise in coronavirus infections and hospitalisations in Maharashtra, experts have said. The symptoms caused by these strains of the virus are mild, they noted. Dr Anita Mathew, Infectious Disease Specialist at Fortis Hospital, Mulund, said many of the new patients are asymptomatic. She told PTI,

Many people have incidental COVID-19. In other words, they are visiting the hospital for other health conditions and test positive for the coronavirus infection.

Also Read: Omicron BA.2 Less Severe Than Its Original And Delta Variants: Study

Symptoms such as the loss of smell and taste, observed prominently in earlier infections, have not been noticed in many patients. Many of them report cold and cough, which is why there isn’t a lot of testing or self-isolation, Dr Mathew added.

She, however, stressed that vaccination against coronavirus was still important. She said,

One should be careful so that the risk of infecting others decreases.

As per the state health department, 17 per cent more COVID-19 cases were recorded during October 10 to 16 against the preceding week (October 3-9). The rise was noticed mainly in Thane, Raigad and Mumbai, all densely-populated districts.

The department had also cautioned that coronavirus cases could rise during winter and the festive season, citing new variants which have greater immune evasive ability.

Also Read: Some Countries May See Another Wave Of COVID-19 Infection Due To XBB Subvariant, Says WHO Chief Scientist

Dr Vasanthapuram Ravi, Virologist, Head, R&D, TATA Medical and Diagnostics (and Chairman of Karnataka Genomic Surveillance Committee) said the new strain of virus and the disease genotype were no different from Omicron in terms of severity and asymptomatic status. He said,

It is a hybrid of two Omicron variants, 3.75 and BJ1, due to which it has a novel mutation in the spike proteins which makes it escape the antibodies generated by vaccines. This is why it is causing infections even in vaccinated people.

But there is not much to worry due to its lessened severity though testing is still important, he added.

If a patient tests positive for Omicron, he or she can get treatment for Omicron infection, Dr Ravi said.

But if the test is negative for Omicron (despite symptoms) then one needs to immediately consult a physician in case there is a presence of a new variant or another virus like flu virus or RSV (respiratory syncytial virus), he added.

Also Read: WHO Chief Scientist On Banega Swasth India Telethon: Key Learnings From COVID-19 Pandemic

The Indian SARS-CoV-2 Genomics Consortium (INSACOG), in a statement, said it was keeping a close watch on the emergence and evolution of XBB and XBB.1 and any new sub-lineages.

But Indian patients infected with Omicron sub-lineage XBB of COVID-19 have mild disease, it went on to add.

Dr Laxman Jessani, Consultant, Infectious Diseases at Apollo hospitals in Navi Mumbai, said the chances of hospitalisation and ICU admissions are low as the infections are mostly mild.

He too said that there was no significant rise in cases in the last few weeks.

“High-risk groups and elderly people should avoid going out to prevent getting infected, especially in crowded places,” he said, adding that wearing a mask is a must.

Also Read: Children With Immunodeficiency At Higher Risk Of Serious COVID-19: Study

(This story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – the LGBTQ populationindigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fight malnutrition, mental wellbeing, self care, science and health, adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diarrhoea and the country can become a Swasth or healthy India.

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version